NeoMatrix - Breast Health Solutions
Breast Cancer Risk Factors
Assessments and Screening Methods
Nipple Aspirate Fluid (NAF) Analysis
Doctorfinder
Practice Assistance Login - Please enter your username.
Please enter your password.
Forgot password?
Click here to find a doctor in your area. Forgot Password?
Site Search
About NeoMatrix Breast Health Information HALO Breast Pap Test Healthcare Professionals Resources and Tools Investor Relations Contact Information

This content requires the Macromedia Flash Player. Get Flash
Nipple Aspirate Fluid (NAF) Analysis
  • Most breast cancers start in the milk ducts
  • Cells from Nipple Aspirate Fluid (NAF) can provide clues to a woman's breast health; routine screening will alert a woman and her doctor to changes in her cytology
  • A finding of atypia, years before it might develop into a lesion, will allow a woman and her doctor the opportunity to chart the optimal care path
After more than fifty years of research, it is now recognized that almost all breast cancers begin in the breast milk ducts. Clinical studies have also confirmed the ability to detect early cellular changes within the breast ducts—similar to the Pap test detection of early cervical cellular changes—through analysis of Nipple Aspirate Fluid (NAF).

Women typically have an average of 6 to 9 ducts in each breast. In 1958, Dr. Papanicolaou (recognized as the originator of the "Pap Test") found it was possible to extract small drops of fluid from the milk ducts by applying suction to the nipple. A cytopathologist can analyze this Nipple Aspirate Fluid (NAF) looking for epithelial cells contained within it. These epithelial cells may be categorized as normal, hyperplasia, atypical hyperplasia, carcinoma in situ or even suggestive of invasive cancer.

Epithelial Cell Categories - Nipple Aspirate Fluid Analysis

Long-term patient follow-up has confirmed the utility of Nipple Aspirate Fluid (NAF) cytology to predict breast cancer risk. Additionally, Nipple Aspirate Fluid screening may detect a cancerous growth years before mammography or physical examination.

Abnormal Cell Growth Detection through Nipple Aspirate Fluid Analysis

Back to top
Home   |   About NeoMatrix   |   Breast Health Information   |   HALO™ Breast Pap Test   |   Healthcare Professionals
Resources and Tools   |   Investor Relations   |   Contact Information   |   Privacy Policy   |   Site Map
Breast Cancer Statistics   |   Early Signs of Breast Cancer   |   Breast Cancer Signs and Symptoms
Copyright 2008 NeoMatrix, LLC. All Rights Reserved. 16 Technology Drive, Suite 118, Irvine, CA 92618 . 949.753.7844